| 000 | 01776 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517151906.0 | ||
| 264 | 0 | _c20190722 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/srep46679 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFernández-Laso, Valvanera | |
| 245 | 0 | 0 |
_aTWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice. _h[electronic resource] |
| 260 |
_bScientific reports _c04 2017 |
||
| 300 |
_a46679 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 |
_aAtherosclerosis _xgenetics |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemokine CCL5 _xgenetics |
| 650 | 0 | 4 |
_aChemokine CXCL10 _xgenetics |
| 650 | 0 | 4 |
_aCytokine TWEAK _xgenetics |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xgenetics |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
| 650 | 0 | 4 |
_aPlaque, Atherosclerotic _xgenetics |
| 650 | 0 | 4 |
_aSTAT1 Transcription Factor _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aSastre, Cristina | |
| 700 | 1 | _aMéndez-Barbero, Nerea | |
| 700 | 1 | _aEgido, Jesús | |
| 700 | 1 | _aMartín-Ventura, Jose L | |
| 700 | 1 | _aGómez-Guerrero, Carmen | |
| 700 | 1 | _aBlanco-Colio, Luis M | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gp. 46679 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep46679 _zAvailable from publisher's website |
| 999 |
_c27118043 _d27118043 |
||